Objective Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterised by variable treatment responses. We investigated the transcriptional landscape associated with treatment ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

Despite current guidelines, systemic lupus erythematosus treatment trends in the US show a large number of patients do not receive antimalarials. Systemic lupus erythematosus (SLE) treatment trends in ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle ...

Therefore, clarifying how negative immune checkpoints function and the mechanisms involved can provide a new idea for the clinical treatment of diseases. This Research Topic will focus on the ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Baseline factors linked to SLE flares during pregnancy included thrombocytopenia and a history of LN, while antimalarial therapy demonstrated protective effects.